Severity of a COVID-19 illness could be determined by examining autoantibodies in the nasal cavity, allowing more personalized treatment protocols. Severe COVID-19 can be life-threatening for patients ...

As respiratory viruses begin circulating across Canada, many families are left wondering what to do when illness strikes at home. To help provide greater clarity, Abbott (NYSE: ABT) today announced ...

CoV-2, the virus that causes COVID-19, and Influenza A and Influenza B from one nasal swab. Abbott Panbio COVID-19/Flu A&B ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

Abbott ( ABT) announced the availability of its Panbio COVID-19/Flu A&B Self-Test across Canada, offering families a way to check for COVID-19 and influenza A and B using a single nasal swab. The test ...

Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a common nasal spray could help prevent infection. This randomized ...

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans. A wide ...

New research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity. A wide variety of COVID-19 symptoms ...